Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: Impact on outcome reporting
(Article)
Vranckx, P. Farooq, V. Garg, S.A. Es, G.A. van Silber, S. Windecker, S. Stone, G.W. Serruys, P.W.J.C.
|
2012-10-01
|
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents: Pooled analysis from the SPIRIT (Clinical evaluation of the XIENCE v everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials
(Article)
Claessen, B.E. Smits, P.C. Sood, P. Simonton, C. Stone, G.W. Kereiakes, D.J. Parise, H. Fahy, M. Kedhi, E. Serruys, P.W.J.C. Lansky, A.J. Cristea, E. Sudhir, K.
|
2011-11-01
|
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: Pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trials
(Article)
Planer, D. Smits, P.C. Kereiakes, D.J. Kedhi, E. Fahy, M. Xu, K. Serruys, P.W.J.C. Stone, G.W.
|
2011-10-01
|
Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus
(Article)
Stone, G.W. Kedhi, E. Kereiakes, D.J. Parise, H. Fahy, M. Serruys, P.W.J.C. Smits, P.C.
|
2011-08-23
|
A prospective natural-history study of coronary atherosclerosis
(Article)
Stone, G.W. Maehara, A. Parise, H. Templin, B. White, R. Zhang, Z. Serruys, P.W.J.C. Lansky, A.J. Bruyne, B. de Cristea, E. Mintz, G.S. Mehran, R. McPherson, J. Farhat, N. Marso, S.P.
|
2011-01-20
|
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: A pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE v Everolimus Eluting Coronary Stent System [EECSS]
(Article)
Caixeta, A. Lansky, A.J. Sood, P. Su, X. Jonnavithula, L. Sudhir, K. Stone, G.W. Serruys, P.W.J.C. Hermiller, J.B. Ruygrok, P.N. Onuma, Y. Gordon, P. Yaqub, M. Miquel-Hébert, K. Veldhof, S.
|
2010-12-01
|
Clinical and angiographic risk assessment in patients with left main stem lesions
(Article)
Garg, S.A. Stone, G.W. Kappetein, A.P. Sabik, J.F. Simonton, C. Serruys, P.W.J.C.
|
2010-09-01
|
An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials
(Article)
Bartorelli, A. Serruys, P.W.J.C. Miquel, K. Yu, S. Pierson, W. Stone, G.W.
|
2010-07-01
|
Randomized comparison of everolimus-and paclitaxel-eluting stents: Pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials
(Article)
Onuma, Y. Serruys, P.W.J.C. Kukreja, N. Veldhof, S. Doostzadeh, J. Cao, S. Stone, G.W.
|
2010-05-01
|
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound
(Article)
Kubo, T. Maehara, A. Margolis, M.P. Foster, M.C. Bruyne, B. de Leon, M.B. Stone, G.W. Mintz, G.S. Garcia-Garcia, H.M. Serruys, P.W.J.C. Suzuki, T. Klauss, V. Sumitsuji, S. Lerman, A. Marso, S.P.
|
2010-02-01
|
